1 Min Read
Jan 4 (Reuters) - Alimera Sciences Inc:
* ALIMERA SCIENCES RECEIVES ACCEPTANCE OF FILING TO OBTAIN APPROVAL FOR ILUVIEN® NON-INFECTIOUS POSTERIOR UVEITIS INDICATION IN EUROPE Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.